281 related articles for article (PubMed ID: 32152245)
1. Systems Biological Analysis of Immune Response to Influenza Vaccination.
Cortese M; Sherman AC; Rouphael NG; Pulendran B
Cold Spring Harb Perspect Med; 2021 Jun; 11(6):. PubMed ID: 32152245
[TBL] [Abstract][Full Text] [Related]
2. Inactivation methods for whole influenza vaccine production.
Sabbaghi A; Miri SM; Keshavarz M; Zargar M; Ghaemi A
Rev Med Virol; 2019 Nov; 29(6):e2074. PubMed ID: 31334909
[TBL] [Abstract][Full Text] [Related]
3. The Quest for a Truly Universal Influenza Vaccine.
Jang YH; Seong BL
Front Cell Infect Microbiol; 2019; 9():344. PubMed ID: 31649895
[TBL] [Abstract][Full Text] [Related]
4. Immunobiology of influenza vaccines.
Gomez Lorenzo MM; Fenton MJ
Chest; 2013 Feb; 143(2):502-510. PubMed ID: 23381315
[TBL] [Abstract][Full Text] [Related]
5. The Future of Flu: A Review of the Human Challenge Model and Systems Biology for Advancement of Influenza Vaccinology.
Sherman AC; Mehta A; Dickert NW; Anderson EJ; Rouphael N
Front Cell Infect Microbiol; 2019; 9():107. PubMed ID: 31065546
[No Abstract] [Full Text] [Related]
6. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
7. Public Health-Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union.
Navarro-Torné A; Hanrahan F; Kerstiëns B; Aguar P; Matthiessen L
Emerg Infect Dis; 2019 Feb; 25(2):. PubMed ID: 30666948
[TBL] [Abstract][Full Text] [Related]
8. Reverse vaccinology approach to design a novel multi-epitope subunit vaccine against avian influenza A (H7N9) virus.
Hasan M; Ghosh PP; Azim KF; Mukta S; Abir RA; Nahar J; Hasan Khan MM
Microb Pathog; 2019 May; 130():19-37. PubMed ID: 30822457
[TBL] [Abstract][Full Text] [Related]
9. Influenza vaccination strategies targeting the hemagglutinin stem region.
Fukuyama H; Shinnakasu R; Kurosaki T
Immunol Rev; 2020 Jul; 296(1):132-141. PubMed ID: 32542739
[TBL] [Abstract][Full Text] [Related]
10. Seasonal Variability and Shared Molecular Signatures of Inactivated Influenza Vaccination in Young and Older Adults.
Avey S; Mohanty S; Chawla DG; Meng H; Bandaranayake T; Ueda I; Zapata HJ; Park K; Blevins TP; Tsang S; Belshe RB; Kaech SM; Shaw AC; Kleinstein SH
J Immunol; 2020 Mar; 204(6):1661-1673. PubMed ID: 32060136
[TBL] [Abstract][Full Text] [Related]
11. Novel Approaches for The Development of Live Attenuated Influenza Vaccines.
Blanco-Lobo P; Nogales A; Rodríguez L; Martínez-Sobrido L
Viruses; 2019 Feb; 11(2):. PubMed ID: 30813325
[TBL] [Abstract][Full Text] [Related]
12. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
; Ampofo WK; Baylor N; Cobey S; Cox NJ; Daves S; Edwards S; Ferguson N; Grohmann G; Hay A; Katz J; Kullabutr K; Lambert L; Levandowski R; Mishra AC; Monto A; Siqueira M; Tashiro M; Waddell AL; Wairagkar N; Wood J; Zambon M; Zhang W
Influenza Other Respir Viruses; 2012 Mar; 6(2):142-52, e1-5. PubMed ID: 21819547
[TBL] [Abstract][Full Text] [Related]
13. [Progress in new vaccine strategies against influenza: a review].
Liu Z; Jiang T; Qin E; Ran D; Qin C
Sheng Wu Gong Cheng Xue Bao; 2012 May; 28(5):550-6. PubMed ID: 22916493
[TBL] [Abstract][Full Text] [Related]
14. Is a Universal Influenza Virus Vaccine Possible?
Nachbagauer R; Palese P
Annu Rev Med; 2020 Jan; 71():315-327. PubMed ID: 31600454
[TBL] [Abstract][Full Text] [Related]
15. A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains.
Ross TM; DiNapoli J; Giel-Moloney M; Bloom CE; Bertran K; Balzli C; Strugnell T; Sá E Silva M; Mebatsion T; Bublot M; Swayne DE; Kleanthous H
Vaccine; 2019 Apr; 37(17):2369-2376. PubMed ID: 30905528
[TBL] [Abstract][Full Text] [Related]
16. Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures.
Nakaya HI; Hagan T; Duraisingham SS; Lee EK; Kwissa M; Rouphael N; Frasca D; Gersten M; Mehta AK; Gaujoux R; Li GM; Gupta S; Ahmed R; Mulligan MJ; Shen-Orr S; Blomberg BB; Subramaniam S; Pulendran B
Immunity; 2015 Dec; 43(6):1186-98. PubMed ID: 26682988
[TBL] [Abstract][Full Text] [Related]
17. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
Lei H; Peng X; Jiao H; Zhao D; Ouyang J
Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
[TBL] [Abstract][Full Text] [Related]
18. Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections.
Calzas C; Chevalier C
Front Immunol; 2019; 10():1605. PubMed ID: 31379823
[TBL] [Abstract][Full Text] [Related]
19. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.
Isakova-Sivak I; Rudenko L
Expert Rev Vaccines; 2015; 14(10):1313-29. PubMed ID: 26289975
[TBL] [Abstract][Full Text] [Related]
20. Innate gene signature distinguishes humoral versus cytotoxic responses to influenza vaccination.
Gonçalves E; Bonduelle O; Soria A; Loulergue P; Rousseau A; Cachanado M; Bonnabau H; Thiebaut R; Tchitchek N; Behillil S; van der Werf S; Vogt A; Simon T; Launay O; Combadière B
J Clin Invest; 2019 May; 129(5):1960-1971. PubMed ID: 30843873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
